Home Agro Science & Research SPARC gains on antibody licensing agreement with Biomodifying

SPARC gains on antibody licensing agreement with Biomodifying

by admin
0 comment
SPARC, Visiox, Pharma, , Industry, Chemical , Agreement, Cancer, Profit, Sale, Company

Synopsis :

  • SPARC enters agreement with Biomodifying to gain rights on antibody to treat cancer

Sun Pharma Advanced Research Company (SPARC) gained 2.54% to Rs 254.80 after the company said that it has entered into a licensing agreement with Biomodifying to acquire exclusive rights for antibody against unique oncology target.

SPARC on Friday said it has entered into an agreement with US-based Biomodifying LLC to exclusively license the latter’s intellectual property, including all patents and patent applications owned or controlled by Biomodifying, along with antibodies developed for multiple uses including for Cancer

SPARC, Biomodifying, Agreement, Cancer, Profit, Sale, Company, Antibody

SPARC gains on antibody licensing agreement with Biomodifying

Under the agreement, Biomodifying is eligible for an up-front payment, milestone payments on pre-specified clinical, regulatory, and commercial milestones, as well as royalties on sales.
In addition, SPARC will pay Biomodifying a percentage of payments received for sublicenses of the licensed IP.“This is an important milestone for SPARC. The licensing of antibodies from Biomodifying will assist us in our endeavour to transition SPARC into a company focussed on novel treatment modalities, including bi-specific antibodies and antibody drug conjugates” said Anil Raghavan, CEO of SPARC.
SPARC is a clinical stage bio-pharmaceutical company, It was formed in 2007 through a demerger from Sun Pharma, a global leader in speciality generics.

The company’s standalone net loss during Q2 FY22 was Rs 55.14 crore as compared to a net loss of Rs 61.37 crore in Q2 FY21. Revenue from operations surged 57.99% YoY to Rs 27.87 crore in Q2 September 2021.


Sun Pharma Advanced Research Company (SPARC) is a clinical stage bio-pharmaceutical company focused on continuously improving standards of care for patients globally, through innovation in therapeutics and delivery. SPARC was formed in 2007 through a demerger from SUN PHARMA, a global leader in speciality generics.

SPARC had out-licensed Elepsia XR to a subsidiary of Sun Pharmaceutical Industries Ltd in July 2016.

About Biomodifying LLC

Biomodifying, LLC is a biotech company dedicated to identifying and exploiting molecules over-expressed by cancer cells by developing next generation novel therapies that specifically target tumors while sparing normal, non-cancerous tissues.


For more Information: Sign in Websites for Agrochemical & Pharmaceutical Databases:

Website : https://www.chemrobotics.com/ (Agrochemical Databases)

Website : https://chemroboticspharma.com/  (Pharmaceutical Databases)

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Our Company

ChemRobotics is a global Scientific, Technical & Business data intelligence company, especially in the field of Pharmaceutical, Agrochemical, Veterinary and Fine Chemical.

ChemRobotics Times

Subscribe ChemRobotics for the latest updates in the Pharmaceutical, Agrochemical, Veterinary, and Fine Chemical Industries

Laest News

ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved. 

Designed and Developed by Ample eBusiness